Advertisement

Topics

Block estrogen to treat lung disease

04:10 EDT 18 Aug 2017 | Medical Xpress

The strongest epidemiological risk factor for many forms of pulmonary arterial hypertension (PAH) is female gender. Increased estrogen makes females three times more likely to develop PAH, a chronic disease that eventually leads to right heart failure and death.

Original Article: Block estrogen to treat lung disease

NEXT ARTICLE

More From BioPortfolio on "Block estrogen to treat lung disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...